These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 23455361)

  • 21. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.
    D'Alto M; Romeo E; Argiento P; D'Andrea A; Sarubbi B; Correra A; Scognamiglio G; Papa S; Bossone E; Calabrò R; Vizza CD; Russo MG
    Int J Cardiol; 2013 Apr; 164(3):323-6. PubMed ID: 21802156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of iloprost combined with low dose tadalafil in adult congenital heart disease patients with severe pulmonary arterial hypertension: a single-center, open-label controlled study].
    Zhang C; Huang Y; Huang T; Xia C; Huang X; Zhang G; Yao H; Chen J; Chen J; Wu S; Zhuang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):474-80. PubMed ID: 25164220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
    D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
    Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease.
    Gatzoulis MA; Alonso-Gonzalez R; Beghetti M
    Eur Respir Rev; 2009 Sep; 18(113):154-61. PubMed ID: 20956136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification.
    van Riel AC; Schuuring MJ; van Hessen ID; Zwinderman AH; Cozijnsen L; Reichert CL; Hoorntje JC; Wagenaar LJ; Post MC; van Dijk AP; Hoendermis ES; Mulder BJ; Bouma BJ
    Int J Cardiol; 2014 Jun; 174(2):299-305. PubMed ID: 24794056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.
    Apostolopoulou SC; Manginas A; Cokkinos DV; Rammos S
    Heart; 2007 Mar; 93(3):350-4. PubMed ID: 16980516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease.
    Schuuring MJ; Bouma BJ; Cordina R; Gatzoulis MA; Budts W; Mullen MP; Vis JC; Celermajer D; Mulder BJ
    Int J Cardiol; 2013 Mar; 164(1):106-10. PubMed ID: 21763017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension.
    Blumberg FC; Arzt M; Lange T; Schroll S; Pfeifer M; Wensel R
    Eur J Heart Fail; 2013 Jul; 15(7):771-5. PubMed ID: 23507788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease.
    Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Straalen JP; Boekholdt SM; Tijssen JG; Mulder BJ; Bouma BJ
    Congenit Heart Dis; 2013; 8(6):520-6. PubMed ID: 23241414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease.
    Zhang HD; Yan Y; He YY; Liu QQ; Peng FH; Yan XX; Han ZY
    Int J Cardiol; 2023 Mar; 375():29-35. PubMed ID: 36565957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease.
    Vis JC; Duffels MG; Mulder P; de Bruin-Bon RH; Bouma BJ; Berger RM; Hoendermis ES; van Dijk AP; Mulder BJ
    Int J Cardiol; 2013 Mar; 164(1):64-9. PubMed ID: 21723630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.
    Lunze K; Gilbert N; Mebus S; Miera O; Fehske W; Uhlemann F; Mühler EG; Ewert P; Lange PE; Berger F; Schulze-Neick I
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():32-8. PubMed ID: 16919008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary arterial hypertension after operation for congenital heart disease: analysis of baseline clinical characteristics of 122 Chinese patients].
    Sun M; Cheng C; Zhang R; Xu X; Wen L; Sun K; Jiang X; Wang X; Jing Z
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):396-9. PubMed ID: 25042918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension: results from a long-term, single center, real-world follow-up.
    Favilli S; Spaziani G; Ballo P; Fibbi V; Santoro G; Chiappa E; Arcangeli C
    Intern Emerg Med; 2015 Jun; 10(4):445-50. PubMed ID: 25573622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database.
    Patel ND; Weiss ES; Allen JG; Russell SD; Shah AS; Vricella LA; Conte JV
    Ann Thorac Surg; 2009 Sep; 88(3):814-21; discussion 821-2. PubMed ID: 19699904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
    Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
    Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
    Monfredi O; Griffiths L; Clarke B; Mahadevan VS
    Am J Cardiol; 2011 Nov; 108(10):1483-8. PubMed ID: 21943933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.